Modus Therapeutics receives SEK 134,066 from warrant exercise
The company said 335,166 TO 2030 warrants were exercised in the first exercise period, raising about SEK 134,000 before costs at SEK 0.40 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.